Cargando…
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
BACKGROUND: SARS-CoV-2 can induce an immune impairment and dysregulation, finally resulting in the massive release of inflammatory mediators (cytokine storm), strongly contributing to the pulmonary and systemic manifestations in severe coronavirus disease 2019 (COVID-19). As a consequence, different...
Autores principales: | Costagliola, Giorgio, Spada, Erika, Consolini, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094984/ https://www.ncbi.nlm.nih.gov/pubmed/33947420 http://dx.doi.org/10.1186/s12969-021-00559-5 |
Ejemplares similares
-
Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19
por: Costagliola, Giorgio, et al.
Publicado: (2021) -
Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications
por: Costagliola, Giorgio, et al.
Publicado: (2021) -
The Challenge of Managing Children With Periodic Fever Syndromes in the Era of COVID-19
por: Consolini, Rita, et al.
Publicado: (2021) -
Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood
por: Costagliola, Giorgio, et al.
Publicado: (2018) -
Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
por: Costagliola, Giorgio, et al.
Publicado: (2021)